NeOnc Technologies Appoints David Choi as Chief Accounting Officer with Significant Equity Grant

summarizeSummary

NeOnc Technologies Holdings, Inc. has appointed David Choi as its new Chief Accounting Officer, effective March 12, 2026, bolstering its financial leadership with a seasoned CPA and granting him 170,000 restricted shares.

check_boxKey Events · Executive and Board Changes · NTHI

• New Chief Accounting Officer Appointed

  David Choi was appointed as Chief Accounting Officer, effective March 12, 2026, bringing over a decade of experience in financial reporting and internal controls.

• Significant Equity Compensation

  Mr. Choi received a grant of 170,000 restricted shares under the 2023 Equity Incentive Plan, with 53,333 shares vesting immediately and the remainder vesting over time and based on performance.

• Strengthens Financial Leadership

  This appointment is expected to enhance the company's accounting, financial reporting, internal controls, and corporate governance functions during a period of clinical advancement and global expansion.

auto_awesomeAnalysis · NTHI · Life Sciences

The appointment of David Choi as Chief Accounting Officer is a positive development for NeOnc Technologies, particularly as the company is in a clinical-stage and expanding its operations. Mr. Choi's extensive background in accounting, financial reporting, and internal controls from top advisory firms like Blythe Global Advisors, Grant Thornton, and Ernst & Young is crucial for strengthening the company's financial infrastructure and ensuring compliance as a public entity. The compensation package, including a base salary of $162,500 and a grant of 170,000 restricted shares, aligns with attracting experienced C-suite talent. This move enhances corporate governance and financial oversight, which is vital for investor confidence and future growth.